Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The interleukin-10 gene promoter polymorphism (-1082) does not correlate with clinical outcome in diffuse large B-cell lymphoma

2 Jun 2005

Abstract excerpt

The interleukin-10 gene promoter polymorphism (-1082) does not correlate with clinical outcome in diffuse large B-cell lymphoma.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Immune Cell Function and Interaction
Share to Lymphoma Diagnosis and Treatment
Share to T-cell and Retrovirus Studies

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 15933064
DOI: 10.1182/blood-2004-12-4814

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The interleukin-10 gene promoter polymorphism (-1082) does not correlate with clinical outcome in diffuse large B-cell lymphomaPMID 15933064Read ↗

Interleukin-10 gene promoter polymorphisms influence the clinical outcome of diffuse large B-cell lymphoma.Semantic proximity Read ↗

Interleukin‐10 gene polymorphisms influence the clinical course of non‐Hodgkin’s lymphomaSemantic proximity Read ↗

Genetic association of interleukin-10 promoter polymorphisms and susceptibility to diffuse large B-cell lymphoma: a meta-analysis.Semantic proximity Read ↗

Polymorphisms in the interleukin 10 gene promoter are associated with susceptibility to aggressive non-Hodgkin's lymphoma.Semantic proximity Read ↗

Clinical significance of interleukin-10 gene polymorphisms and plasma levels in Hodgkin lymphoma.Semantic proximity Read ↗

Polymorphisms of interleukin-10 promoter are not associated with prognosis of advanced gastric cancer.Semantic proximity Read ↗

The interleukin-10-1082 G/A polymorphism: allele frequency in different populations and functional significance.Semantic proximity Read ↗

Interleukin-10 gene polymorphism influences the prognosis of T-cell non-Hodgkin lymphomas.Semantic proximity Read ↗

Association of interleukin-10, tumor necrosis factor-α and transforming growth factor-β gene polymorphisms with the outcome of diffuse large B-cell lymphomas.Semantic proximity Read ↗

Influence of interleukin-10 genetic polymorphism on survival rates in melanoma patients with advanced disease.Semantic proximity Read ↗

Interleukin-10 (IL10) promoter polymorphisms and multiple sclerosis.Semantic proximity Read ↗

Interleukin-10 promoter polymorphism in patients with rheumatoid arthritisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.